May 9, 2025 05:15 AM EDTUpdated 10:56 AM

AI biotech Insilico Medicine goes for third attempt at Hong Kong IPO

Kyle LaHucik

Biotech Correspondent

Insilico Medicine is hoping to ride a recent wave of momentum for biotech startups on the Hong Kong Stock Exchange.

The biotech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Supreme Court to keep mulling state PBM dispute as US urges justices to decline case

Large pharma companies spell out reasons why tariffs will harm US investments

Merck, Daiichi Sankyo scrap FDA application for HER3 ADC after survival miss

DNA giant Illumina spawned an ecosystem of competitors and customers

FDA rejects Stealth's rare disease drug, but offers potential for accelerated approval

sponsored

From weeks to days: how Aizon Intelligent Agents transform pharma validation